Vanda Pharmaceuticals Inc.

NASDAQ:VNDA

4.85 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income 2.5096.27533.15223.337115.55325.208-15.567-18.01-39.86520.186-20.255-27.664-9.8027.192-35.859-51.064-74.07-63.511-23.884-9.474
Depreciation & Amortization 3.012.7332.8412.8642.8922.9562.98411.86813.5542.7841.9272.1281.9641.8311.4250.5310.5720.5750.4240.377
Deferred Income Tax -1.2861.136.7456.189-87.767-2.221-0.426-0.1040.6770.17400.561.821-1.8210-0-19.594-6,131.79700
Stock Based Compensation 14.0416.27915.37413.3613.45811.66610.4658.5437.9615.8784.6044.0945.5014.98111.2313.38819.6236,131.82700
Change In Working Capital -0.7476.0742.7374.3173.125-7.79-0.026-11.10829.465-32.96-26.023-25.861-28.794-20.378192.402-8.5743.7775.5340.6860.417
Accounts Receivables -0.707-1.089-2.469-3.7672.342-11.2072.525-4.298-12.677-1.623-0.8630.45-1.1072.653-3.16400000
Inventory -0.771-4.479-2.233-2.876-0.7220.07-1.060.20.387-2.211.255-0.057-1.672.399-2.39900000
Accounts Payables -10.98411.7933.047.8270.744-4.8765.9530.5759.4320.1740.374-0.7090.348-1.7751.911-2.4760.204526.71100
Other Working Capital 11.715-0.1514.3993.1330.7618.223-7.444-7.58532.323-29.301-26.789-25.545-26.365-23.655196.053-6.0993.573-521.1770.6860.417
Other Non Cash Items -4.725-0.5073.3651.708-1.3140.1670.5870.7080.657-77.6160.1551.8260.9-2.7030.138-0.23518.0515.7535.060.066
Operating Cash Flow 12.80131.98464.21451.77545.94729.986-1.983-8.10312.449-81.554-39.592-44.917-28.41-10.898169.336-45.955-51.641-51.62-17.714-8.615
Investing Activities:
Investments In Property Plant And Equipment -0.383-0.679-0.552-1.795-1.019-25.368-1.664-1.407-2.527-8.769-0.176-2.017-0.2750-12-0.944-0.279-1.354-0.292-0.415
Acquisitions Net -100.665-50.604-0.012-0.22967.2925000-800001200000
Purchases Of Investments -512.606-349.258-420.461-346.622-394.517-282.395-148.135-165.405-193.111-93.343-65.598-60.866-160.213-202.438-11.366-14.786-138.954-102.233-11.8460
Sales Maturities Of Investments 601.598399.862344.317306.918327.227198.103139.568156.787169.0489.8331.499108.637234.83746.7518.62758.81890.273111.8081.750
Other Investing Activites 88.99250.6040.0120.229-67.29-250.124-0.046-24.0718.245-34.09947.771-0.60.066-1200.20-0.430
Investing Cash Flow -12.05649.925-76.696-41.499-68.309-109.66-10.107-10.071-26.598-12.037-34.27545.75473.749-155.622-4.73943.088-48.768.221-10.818-0.415
Financing Activities:
Debt Repayment 0000000000000000000-0.199
Common Stock Issued 00.7343.555.6346.264107.1265.2517.7514.37487.31348.50500000111.40353.45733.5180
Common Stock Repurchased 00000000-0.283-0.436-0.196000000000
Dividends Paid 00000000000000000000
Other Financing Activities 00.7343.555.6346.264107.1265.2517.7514.0912.41550.0550.0120.0253.7841.61900.149-0.143-0.22418.345
Financing Cash Flow 00.7343.555.6346.264107.1265.2517.7514.09189.72849.8590.0120.0253.7841.6190111.40353.31433.29418.146
Other Information:
Effect Of Forex Changes On Cash 0.0470.265-0.0910.053-0.001-0.0380.040.00600000000.017-0.0010-0.009-0.022
Net Change In Cash 0.79282.908-9.02315.963-16.09927.414-6.799-10.417-10.058-3.863-24.0080.84945.364-162.736166.216-2.8511.0019.9164.7539.094
Cash At End Of Period 135.821135.49852.5961.61345.6561.74933.62740.42650.84360.90164.76488.77287.92342.559205.29539.07941.9330.92921.01316.26